Coenzyme Supplements: Methylcobalamin and Adenosylcobalamin

by Jack Norris, Registered Dietitian

Contents

• Summary
• Introduction
• Adequate Doses of Methylcobalamin
• Bibliography

Note: I used AI for the literature review, data analysis, claim verification, and editing of this article. Last updated: June 2026.

Summary

Cyanocobalamin is a well-studied, reliable, inexpensive form of vitamin B12, though it does contain a molecule of cyanide, which, in normal amounts, should be physiologically inconsequential for people without kidney disease. Many alternative health practitioners and supplement companies promote the coenzyme forms of B12, methylcobalamin and adenosylcobalamin. Requirements for these alternative forms have not been fully elucidated; common recommendations have been for 1,000 µg/day. A 2026 study suggests that 50 µg per day of methylcobalamin is adequate as a stand-alone supplement; multivitamins might be less reliable.

Introduction

There are four forms of vitamin B12, differentiated by the side group attached to the cobalamin molecule:

Cyanocobalamin: Most stable and inexpensive form. Used for fortified foods. Absorption and impact on B12 status has been well studied. Contains cyanide in physiologically insignificant amounts (see Cyanocobalamin, Cyanide, and Kidney Disease).

Hydroxocobalamin: Usually the form in B12 injections; hydroxyl side group has the least attraction to the cobalamin molecule.

Adenosylcobalamin: Co-enzyme form. Also known as 5′-deoxy-5′-adenosylcobalamin, dibencozide, cobamamide, and cobinamide.

Methylcobalamin: Co-enzyme form. Once absorbed, methylcobalamin may be retained in the body better than cyanocobalamin (Okuda, 1973).

The body requires both of the co-enzyme forms of B12 for different functions. For this reason, supplements of the coenzyme forms are sometimes promoted as being superior; but this isn’t the case because the oral forms of B12 are stripped of their side groups by the target cell before being reconfigured (Obeid, 2015).

At doses of 1, 5, and 25 µg, all four forms were absorbed at roughly similar rates, with retention declining as dose increased: ~44–56% at 1 µg, ~13–20% at 5 µg, and ~6–8% at 25 µg (Adams, 1971). Despite these similar absorption rates, there have been questions about the stability of the coenzyme forms in supplements and, therefore, large daily doses are typically recommended.

Adequate Doses of Methylcobalamin

Only doses of the methylcobalamin co-enzyme form have been studied, with the most compelling evidence coming from a 2026 study suggesting that a daily dose of 50 µg of methylcobalamin, for a few months, is sufficient to improve or maintain vitamin B12 status.

Case studies. Some researchers question whether the coenzyme supplements are stable in their oral form and usually recommend high doses of methylcobalamin, typically 1,000 µg/day. Small case studies have shown methylcobalamin to improve B12 status in doses of 1,500 µg/day (Kim, 2011), 1,000-2,000 µg/day (Donaldson, 2000, USA), ~1,000 µg 1 to 7 times a week (Zugrav, 2021, Romania), and 500 µg 3 to 4 times a week (Storz, 2024, Germany).

METCOBIND. The MATCOBIND study, from India and Nepal, was a randomized, double-blinded trial of 531 predominantly vegetarian women with low B12-status (baseline serum B12: median ~185 pg/mL; holotranscobalamin: median ~28.6 pmol/L). In their first trimester of pregnancy, the women were started on oral methylcobalamin supplements at 250 µg/day (Group A, n=255) or 50 µg/day (Group B, n=276). Third-trimester holotranscobalamin values were 78.2 pmol/L (IQR 52.2–116.5) in Group A and 65.3 pmol/L (IQR 49.2–96.6) in Group B. MMA wasn’t measured (Nagpal, 2026). Note: Holotranscobalamin is considered by modern biochemistry to be selective for active vitamin B12 (Nexo, 2011).

Multivitamins. In a test-tube solution, methylcobalamin is considerably less stable than cyanocobalamin when combined with other common supplement ingredients, particularly vitamin C, thiamin, and niacin; sorbitol was found to significantly protect methylcobalamin (Hadinata Lie, 2020). People taking methylcobalamin as part of a multivitamin should be aware that they might not be getting the full dose listed on the bottle, but that sorbitol in the multivitamin may help counteract this degradation.

Bibliography

Adams JF, Ross SK, Mervyn L, Boddy K, King P. Absorption of cyanocobalamin, coenzyme B 12 , methylcobalamin, and hydroxocobalamin at different dose levels. Scand J Gastroenterol. 1971;6(3):249-52.

Donaldson MS. Metabolic vitamin B12 status on a mostly raw vegan diet with follow-up using tablets, nutritional yeast, or probiotic supplements. Ann Nutr Metab. 2000;44(5-6):229-34. The subjects receiving methylcobalamin was only a small part of this paper, mentioned on p. 232. They studied 3 vegans with elevated urinary MMA levels who were treated with 1/2 to 1 sublingual methylcobalamin tablet, 2 times/day for 3 weeks. Correspondence with the author (March 21, 2002) verified that these tablets contained 1,000 µg methylcobalamin each. Two of the subjects’ urinary MMA normalized while the remaining subject’s stayed slightly elevated at 4.1 µg/mg creatinine (normal is < 4.0 µg/mg creatinine). Thus, at a rate of 1,000-2,000 µg/day, methylcobalamin appears to be absorbed at a high enough rate to improve B12 status in some vegans. Additionally, this indicates that the methylcobalamin was converted to adenosylcobalamin for use in the MMA pathway.

Hadinata Lie A, V Chandra-Hioe M, Arcot J.Hadinata Lie A, V Chandra-Hioe M, Arcot J. Sorbitol enhances the physicochemical stability of B12 vitamers. Int J Vitam Nutr Res. 2020 Oct;90(5-6):439-447. In solution, methylcobalamin losses of 48–76% were observed in the presence of thiamin and niacin, and 72–76% in the presence of ascorbic acid, compared to 6–21% and 6–13% losses for cyanocobalamin under the same conditions. Sorbitol, added as a stabilizer, reduced methylcobalamin losses to approximately 8% for thiamin and niacin (the abstract says 20%, but the text says 8%), and 16% for ascorbic acid. Methylcobalamin was also highly unstable at low pH (79% loss at pH 3), relevant for gummy or chewable formats. The study didn’t test a combination of ascorbic acid, thiamin, and niacin. Cyanocobalamin was the most stable form overall.

Kim HI, Hyung WJ, Song KJ, Choi SH, Kim CB, Noh SH. Oral vitamin B12 replacement: an effective treatment for vitamin B12 deficiency after total gastrectomy in gastric cancer patients. Ann Surg Oncol. 2011 Dec;18(13):3711-7. This clinical trial from Korea found that 3 months of 1,500 µg/day of methylcobalamin raised B12 levels, reduced or eliminated neurological symptoms of B12 deficiency, and lowered homocysteine levels. This trial was done with people who had a gastrectomy and, therefore, had vitamin B12 malabsorption, indicating that for most people 1,500 µg/day would be more than enough.

Mayer G, Kröger M, Meier-Ewert K. Effects of vitamin B12 on performance and circadian rhythm in normal subjects. Neuropsychopharmacology. 1996 Nov;15(5):456-64. In a 23-day, single-blind study without a placebo, healthy adults were randomized to 3,000 µg of methylcobalamin (MB12) or cyanocobalamin (CB12) for 14 days after a 9-day baseline observation; researchers tracked sleep (wrist actigraphy and diaries), self-ratings of alertness/concentration, a brief attention test, and urinary melatonin metabolite (aMT6s) and potassium across five time blocks. Both forms lowered morning aMT6s (suggesting a circadian/alerting shift); MB12 users slept less, and early in treatment their self-ratings (sleep quality, evening freshness, concentration) correlated with MB12 blood levels. Attention scores improved in both groups with no between-group difference; potassium showed small, diet-sensitive changes. However, the study doesn’t justify a conclusion that MB12 is better than CB12 for alertness: there was no control group, key alertness signals are within-group rather than between MB12 and CB12 group comparisons, multiple outcomes/time bins inflate false positives (several p-values are modest), baseline sleep differed between groups, the sample was small and single-blinded, and subjective ratings and diet confound interpretation.

Nagpal J, Mathur M, Rawat S, et al. Maternal supplementation of vitamin B12 in predominantly vegetarian pregnant women improves their vitamin B12 status and the neurodevelopment of their infants: the MATCOBIND multicentric double-blind randomised control trial. BMJ Paediatr Open. 2026 Mar 18;10(1):e004112.

Nexo E, Hoffmann-Lücke E. Holotranscobalamin, a marker of vitamin B-12 status: analytical aspects and clinical utility. Am J Clin Nutr. 2011 Jul;94(1):359S-365S. Holotranscobalamin is considered by modern biochemistry to be selective for active vitamin B12. The other B12-carrying protein, haptocorrin, can bind to inactive B12 analogs. The sum of B12 on holotranscobalamin and B12 on haptocorrin constitutes the total serum B12. Note: That holotranscobalamin binds only active B12 hasn’t been proven by direct experimental evidence in humans, though it’s considered well supported by biochemical binding studies.

Obeid R, Fedosov SN, Nexo E. Cobalamin coenzyme forms are not likely to be superior to cyano- and hydroxyl-cobalamin in prevention or treatment of cobalamin deficiency. Mol Nutr Food Res. 2015 Jul;59(7):1364-72.

Okuda K, Yashima K, Kitazaki T, Takara I. Intestinal absorption and concurrent chemical changes of methylcobalamin. J Lab Clin Med. 1973 Apr;81(4):557-67.

Paul C, Brady DM. Comparative Bioavailability and Utilization of Particular Forms of B12 Supplements With Potential to Mitigate B12-related Genetic Polymorphisms. Integr Med (Encinitas). 2017 Feb;16(1):42-49. Not cited.

Sawangjit R, Thongphui S, Chaichompu W, Phumart P. Efficacy and Safety of Mecobalamin on Peripheral Neuropathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Altern Complement Med. 2020 Dec;26(12):1117-1129. Concluded that mecobalamin (aka methylcobalamin) taken orally (1,500 mg/day), intramuscularly, or intravenously (500 mg/day) may be effective for the treatment of diabetic neuropathy. Not cited.

Storz MA, Huber R, Hannibal L. Impact of vitamin B12 supplement intake cessation on vitamin B12 status in a healthy vegan: A close interval monitoring case study. Nutrition. 2024 May 7;125:112498. A case study of one middle-aged man who had been taking a single oral dose of 500 µg of methylcobalamin and an average of 3 to 4 times a week for many years. His vitamin B12 levels were healthy at 303 pmol/l (409 pg/ml) and his homocysteine level was 11.7 µmol/l (>12 µmol/l is considered unhealthy).

Zugravu CA, Macri A, Belc N, Bohiltea R. Efficacy of supplementation with methylcobalamin and cyancobalamin in maintaining the level of serum holotranscobalamin in a group of plant-based diet (vegan) adults. Exp Ther Med. 2021 Sep;22(3):993. Vegans supplementing with cyanocobalamin had holotranscobalamin levels of 150 pmol/l; those supplementing with methylcobalamin had holotranscobalamin leves of 78.5 pmol/l, which are in the healthy range. The average dose for those supplementing with methylcobalamin was 988 µg, and the frequency was 21% daily, 36% twice per week, and 43% weekly. MMA levels weren’t assessed.